BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+11.62%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
(+16%)
Cap. Flow
+$78.7M
Cap. Flow
% of AUM
6.71%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
149
New
25
Increased
54
Reduced
51
Closed
11
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$12.2M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$12.1M |
| 3 |
Cigna
CI
|
$11.7M |
| 4 |
Viatris
VTRS
|
$9.7M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$8.05M |
Top Sells
| 1 |
Incyte
INCY
|
$11.8M |
| 2 |
UnitedHealth
UNH
|
$11.3M |
| 3 |
Align Technology
ALGN
|
$10.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$9.27M |
| 5 |
Integra LifeSciences
IART
|
$8.56M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Industrials | 0.76% |
| 3 | Technology | 0.15% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Elevance Health
ELV
$71.8B
| $50.8M | 4.33% | 213,527 +32,284 | +18% | +$7.68M |
|
|
2
Align Technology
ALGN
$10.3B
| $44.8M | 3.82% | 131,058 -30,330 | -19% | -$10.4M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $42.3M | 3.61% | 532,800 +98,400 | +23% | +$7.81M |
|
4
Intuitive Surgical
ISRG
$170B
| $42M | 3.58% | 87,739 +5,149 | +6% | +$2.46M |
|
5
Illumina
ILMN
$15.8B
| $39.4M | 3.36% | 140,971 +13,698 | +11% | +$3.83M |
|
6
Abbott
ABT
$231B
| $34.7M | 2.96% | 568,850 +3,850 | +0.7% | +$235K |
|
7
Medtronic
MDT
$119B
| $34.4M | 2.93% | 401,881 +44,881 | +13% | +$3.84M |
|
8
Teladoc Health
TDOC
$1.37B
| $33.1M | 2.82% | 570,110 +54,416 | +11% | +$3.16M |
|
9
Edwards Lifesciences
EW
$47.8B
| $29.9M | 2.55% | 205,660 +8,500 | +4% | +$1.24M |
|
10
Jazz Pharmaceuticals
JAZZ
$7.75B
| $28.4M | 2.42% | 164,933 +13,211 | +9% | +$2.28M |
|
11
Boston Scientific
BSX
$156B
| $26.8M | 2.29% | 820,596 +124,596 | +18% | +$4.07M |
|
12
Humana
HUM
$36.5B
| $25.8M | 2.2% | 86,850 +3,150 | +4% | +$938K |
|
13
DexCom
DXCM
$29.5B
| $25.7M | 2.19% | 270,897 -85,493 | -24% | -$8.12M |
|
|
14
UnitedHealth
UNH
$281B
| $23.7M | 2.02% | 96,729 -45,861 | -32% | -$11.3M |
|
15
Danaher
DHR
$147B
| $21.6M | 1.84% | 218,465 +16,465 | +8% | +$1.62M |
|
|
16
Cigna
CI
$80.3B
| $21.5M | 1.83% | 126,234 +68,584 | +119% | +$11.7M |
|
17
Cencora
COR
$56.5B
| $20.4M | 1.74% | 238,853 +23,675 | +11% | +$2.02M |
|
|
ALXN
18
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $20.3M | 1.73% | 163,730 +32,340 | +25% | +$4.01M |
|
19
Centene
CNC
$14.3B
| $20.1M | 1.71% | 163,247 +43,227 | +36% | +$5.33M |
|
20
Stryker
SYK
$150B
| $20.1M | 1.71% | 118,770 +5,470 | +5% | +$924K |
|
21
Supernus Pharmaceuticals
SUPN
$2.53B
| $19.5M | 1.67% | 326,600 +37,800 | +13% | +$2.26M |
|
22
Becton Dickinson
BDX
$55.3B
| $19.5M | 1.66% | 81,215 +31,215 | +62% | +$7.48M |
|
|
23
Viatris
VTRS
$12.3B
| $18.2M | 1.55% | 502,350 +268,400 | +115% | +$9.7M |
|
|
HRC
24
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $15.7M | 1.34% | 179,689 +21,770 | +14% | +$1.9M |
|
25
Baxter International
BAX
$12.7B
| $15.5M | 1.32% | 210,000 -6,000 | -3% | -$443K |
|